In this Issue:
Exercise and CV event risk in survivors of childhood Hodgkin’s lymphoma
Rituximab optimisation in DLBCL
Rituximab + chemotherapy improves Burkitt’s outcomes
MDS from immunosuppressant-treated aplastic anaemia: efficacy of HSCT
Secondary MGUS after allogeneic SCT in MM
Levofloxacin for preventing infections with bortezomib MM regimens
Myeloid neoplasm risk after solid organ transplants
CALR mutations and long-term survival in ET
Rituximab + doxorubicin in HIV infection with KSHV-MCD
Plasma soluble PD-L1 impacts OS in aggressive DLBCL
Please login below to download this issue (PDF)